J.P. Morgan Securities PLC. Stabilisation Notice (9416L)

TIDMAG99

RNS Number : 9416L

J.P. Morgan Securities PLC.

05 May 2020

05 May 20

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

GlaxoSmithKline Capital plc

Post-stabilisation Period Announcement

Further to the pre-stabilisation period announcement 04 May 20, J.P. Morgan Securities plc, (contact: Emma Lovett 0207 134 2468) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) or the rules of the Financial Conduct Authority) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.

 
Issuer:                     GlaxoSmithKline Capital plc 
Guarantor (if any):         N/A 
Aggregate nominal           GBP Long 8Y - GBP 750mm 
 amount:                     GBP 15Y - GBP 750mm 
                             EUR 3Y - EUR 750mm 
Description:                GBP Long 8Y FXD Senior Unsecured Notes 
                             GBP 15Y FXD Senior Unsecured Notes 
                             EUR 3yr FXD Senior Unsecured Notes 
                             Listing: London Stock Exchange 
Stabilisation Manager(s):   J.P. Morgan Cazenove (Stabilisation 
                             coordinator) 
                             Barclays (Stabilisation Manager(s)) 
                             GSI (Stabilisation Manager(s)) 
                             HSBC (Stabilisation Manager(s)) 
Offer price:                99.954 
 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction

This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

STAEAXSSEESEEEA

(END) Dow Jones Newswires

May 05, 2020 05:22 ET (09:22 GMT)